Mental Health

Add Content

• Definition
• Introduction
• Signs & Symptoms
• Research Summary

Presentation Slides

---

Executive Summary

---

Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Mental Health" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.

Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Mental Health" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.

Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Mental Health" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.

A Review Article published in 2024 in the journal The Natural Products Journal found that Pumpkin seeds are recognised for their medicinal, nutritional, and cosmetic benefits, including anti-diabetic, heart disease prevention, anti-cancer, and antioxidant qualities. The review article undertakes a comprehensive exploration of the nutraceutical importance of pumpkin seeds. The methodology includes an examination of the various known substances in the seeds, such as phytoestrogens, unsaturated fatty acids, and vitamin E. The study then delves into the different benefits and therapeutic uses of these components stretching from medicinal to nutritional to cosmetic applications. The results of this research are diverse and impressive, with implications for several major health sectors. Their potential anti-diabetic and hypoglycemic properties could suggest a significant role in the management and prevention of diabetes. Meanwhile, the seeds' potential in cardiovascular disease prevention could help to address one of the most pressing global health issues. Moreover, potential anti-cancer properties imply that these seeds could even have a part to play in cancer prevention. The review also described potential additional qualities, such as antidepressant, anti-helminthic (parasite-removing), and antioxidant effects.

A Cohort Study published in 2023 in the journal Nutrients found that Long-term consumption of green tea can potentially lessen the risk of depression in postmenopausal women by decreasing inflammation and boosting estradiol levels. In the study, researchers performed an analysis on a tea-producing village, incorporating 386 postmenopausal women in the investigation, who participated either as green tea consumers or non-drinkers (control group). The level of estradiol, inflammation markers, sleep quality, and depression symptoms were measured to uncover any correlations. The results reflected significant disparities between the tea-drinking and control groups in terms of depression and insomnia levels, BMI, inflammation levels, and estradiol quantities. By appraising these outcomes, it was found that green tea intake could quell the likelihood of depression via its impact on sleep, inflammation, and estradiol levels. The risk of depression was consequently seen as reduced among postmenopausal women engaging in regular consumption of green tea.

A Animal Study published in 2023 in the journal Journal of Functional Foods found that Fermented Pueraria lobata root extract and Glycine max extract showed estrogen-like activities, reducing depressive symptoms in menopausal mice but not increasing female cancer risks. The researchers focused on Pueraria lobata roots and Glycine max (also known as soybeans) extracts, which are rich in isoflavones but often limited in practical use due to their high molecular weight and low bioavailability. The researchers chose to ferment these extracts with Lactiplantibacillus plantarum strains which are known to convert glycosides to aglycones, potentially enhancing the beneficial effects of the isoflavones. Specifically, the study was conducted using ovariectomized mice. The research found that both fermented Pueraria lobata root extract and Glycine max extract exhibited estrogen-like activities. More intriguingly, the fermentation process increased the expression of estrogen receptor beta, suggesting that these extracts may not increase the risk of various female cancers—a common side effect of hormone replacement therapy—as was previously believed. Also, the ingestion of these extracts not only increased the estrogen receptor beta in the mice but also upregulated the expression of the brain-derived neurotrophic factor in the hippocampal region of the brain, thus improving depressive symptoms. The highest expression was observed in the group given a mixture of both extracts.

A Systematic Review published in 2023 in the journal Current Sleep Medicine Reports found that There is evidence to support significant improvements to total sleep time and sleep efficiency with the ingestion of tart cherries. We identified a total of 277 unique records, from which 8 studies of low-moderate methodological quality were included in the systematic review. Meta-analysis of subjectively recalled sleep efficiency (SE) and total sleep time (TST) were not significant. Objective SE, however, was significantly higher in the cherry cohort when compared to placebo with an effect size of 0.63 (95% CI 0.29–0.97, P < 0.01). There was low associated heterogeneity (I2 = 0%). Objective TST was significantly higher in the cherry cohorts, with a pooled effect size of 1.21 (95% CI 0.83–1.58, P < 0.01). There was high associated heterogeneity (I2 = 81.5%).

A Review Article published in 2023 in the journal Nutrients found that Vitamin D deficiency could accelerate depressive symptoms and suicide risks, and vitamin D supplementation may mitigate these effects. The paper examines the links between vitamin D deficiency, depression, and suicide from various studies. It hypothesizes that vitamin D could enhance serotonin synthesis and modulate proinflammatory cytokines, both factors in depression and suicide. The paper reviews this hypothesis in the context of the broader health issue of suicide, which is among the leading causes of death worldwide. This paper then discusses the potential benefits of vitamin D supplementation. Drawing upon indirect evidence suggesting that vitamin D deficiencies may be a risk factor for depression—one of the most common factors in suicide attempts—the paper postulates that vitamin D supplementation could play a role in helping to reduce the risk of depression and thus suicide. The beneficial mechanisms of vitamin D, such as enhancing serotonin synthesis and modulating proinflammatory cytokines, which are associated with depression and suicide, stand as the central contributing factors in this hypothesis.

A Animal Study published in 2023 in the journal Behavioural Neurology found that Pumpkin seeds have been shown to provide neuropharmacological benefits such as reducing anxiety and depression, and improving memory. The study evaluated the effects of pumpkin seeds on four areas - anxiety, depression, memory, and motor coordination. Anxiety was tested using models like light and dark apparatus, elevated plus maze, head dip, and open field test, while depression was assessed by the forced swim test and tail suspension test. Memory and learning abilities were gauged through the passive avoidance test, stationary rod apparatus, and Morris's water maze test. The effect on motor skilled learning was assessed by stationary rod and rotarod apparatus. Finally, the levels of brain biogenic amines were determined using reversed phase high-pressure liquid chromatography. In the results evaluation, it was found that pumpkin seeds exhibit properties that help reduce anxiety and alleviate depression, while also enhancing memory. However, they showed no significant effects on motor coordination. An elevated level of norepinephrine was observed, possibly contributing to its antidepressant effects. Furthermore, a reduction in the weight of the animal was observed after chronic administration. These benefits are probably due to the seeds' secondary metabolites like cucurbitacin, beta-sitosterol, polyphenolic compounds, citrulline, kaempferol, arginine, beta-carotene, quercetin, and other antioxidants.

A Theoretical Article published in 2023 in the journal Sleep Medicine Clinics found that Acupuncture may enhance the effectiveness of cognitive-behavioral therapy for people suffering from insomnia and related conditions. The research methodology used in this paper is mainly a theoretical analysis and discussion of the potential synergistic effects of combining cognitive-behavioral therapy for insomnia (CBT-I) and acupuncture. This involves analysis of the current evidence base for the efficacy of acupuncture in treating insomnia and related conditions, along with examination of the practical, logistical, and regulatory aspects of combining these two treatments. In the discussion of their results, the researchers found that there is a growing body of evidence that supports the potential benefit of acupuncture in treating insomnia and its comorbidities, enhancing the current standard treatment approach of CBT-I. This appears to be an innovative approach that could potentially enhance the treatment effectiveness and outcomes for those struggling with insomnia, though it concurrently raises complex issues in terms of its practical and regulatory implementation.

A Review Article published in 2023 in the journal Frontiers in Aging Neuroscience found that Honey exhibits multifaceted benefits for brain health, acting as a memory booster, neuroprotective agent, anti-stress, and anti-nociceptive substance, fostering potential therapeutic applications to enhance overall cognitive well-being. This review scrutinizes 34 original articles exploring the impact of honey on brain health. Honey, traditionally known as a natural sweetener, emerges as a versatile substance with applications in nutrition, health supplementation, and brain health enhancement. The analysis identifies four key benefits: memory enhancement, neuroprotection, stress reduction, and pain alleviation. The review emphasizes the growing interest in understanding the mechanisms that underlie these effects, paving the way for potential therapeutic roles of honey in promoting cognitive well-being. The literature review underscores the significant role of honey in brain health research, shedding light on its diverse benefits, including memory improvement, neuroprotection, stress mitigation, and pain relief. The emphasis on unraveling the underlying mechanisms reflects a broader interest in establishing honey's therapeutic potential for enhancing overall brain health. This comprehensive exploration of honey's effects on cognition opens avenues for developing novel therapeutic strategies harnessing honey's natural properties.

A Experimental Study published in 2023 in the journal Food & Function found that Pu-erh tea can potentially prevent depression-like behaviors induced by nighttime blue light from electronic devices by reshaping gut microbiota and increasing short-chain fatty acids generation. The methodology used involved administering water or Pu-erh tea to two groups of mice for 120 days, followed by a 45-day exposure to a blue light simulating electronic equipment during the night. The effect of the tea and blue light on the mice's behavior and gut microbiota was then studied. Results indicated that the blue light induced depression-like behaviors and upset the gut microbiota in mice that were previously healthy. In the discussion of results, it was noted that the intake of Pu-erh tea significantly reshaped the mice's gut microbiota, especially the metabolism of short-chain fatty acids, which helped protect the integrity of the intestinal barrier. This improvement not only lessened damage to the blood-brain barrier, but also reduced neuroinflammation by inhibiting certain cellular pathways. This ultimately regulated neurotransmitters like brain-derived neurotrophic factor and serotonin, demonstrating the potential of Pu-erh tea to prevent blue light induced depression-like behaviors by impacting the gut-brain axis.

A Cohort Study published in 2022 in the journal Journal of Acupuncture and Meridian Studies found that Acupuncture shows promise in improving psychiatric symptoms, physical symptoms, and quality of life in patients with treatment-resistant mood disorders, highlighting its potential as a complementary therapy for these conditions. This prospective study explored the effects of acupuncture on physical symptoms and quality of life (QoL) in patients with treatment-resistant major depressive disorder (MDD) and bipolar disorder (BD). After 12 weeks of acupuncture treatment, significant improvements were observed in psychiatric symptoms, physical symptoms, and various aspects of QoL. These findings suggest that acupuncture may be beneficial for both the physical and mental well-being of patients with treatment-resistant mood disorders, although further research is needed to validate these preliminary results.

A Systematic Review published in 2022 in the journal Research in Nursing & Health found that Acupuncture, either in isolation or as an adjunct to pharmacological treatment, has clinical benefits and can be considered a safe option for managing depression. A review of 22 trials involving 2,391 participants found that acupuncture can reduce depression severity. Combining acupuncture with antidepressants was more effective than using antidepressants alone or waitlist. However, acupuncture alone or with antidepressants didn't show significant benefits compared to sham acupuncture. Sham acupuncture might have stronger effects than other placebos. Differences in treatment sessions and cultural backgrounds between China and Western countries affect outcomes. Lack of standardization in acupuncture regimens hinders research. Mild adverse events were reported but need better documentation.

A Review Article published in 2022 in the journal Nutrients found that Eating two gold kiwifruit daily can lead to significant improvements in mood and energy, thereby boosting psychological well-being in adults. The study conducted a literature review through databases like CINAHL, Embase, and PubMed, searching for English language articles published from 2005 to July 2022. These articles had to be randomized trials involving kiwifruit interventions targeting adults and assessing psychological well-being. The researchers used the Joanna Briggs Institute's critical appraisal tool to evaluate potential bias in these trials. After the search, they selected two suitable trials involving 202 participants. In discussing the results, the evidence found shows that regularly consuming two gold kiwifruits daily was linked with a significant decrease in mood disturbance and fatigue, and a significant increase in vigor and overall well-being. These effects were more pronounced in participants who had more significant initial mood disturbances. The study concluded by underlining the potential utility of consuming gold kiwifruit daily to promote improved psychological health.

A Randomised Controlled Trial published in 2022 in the journal Nutritional Neuroscience found that Consumption of wild blueberries over six months can improve cognitive performance and speed of processing information amongst older adults. The methodology of this research involved conducting a double-blind, randomized placebo-controlled trial where participants with cognitive issues ascertained by Montreal Cognitive Assessment scores were asked to consume wild blueberry or placebo powder daily for a 6-month period. There was also a separate reference group involved, comprised of individuals devoid of any cognitive issues. These individuals were tested at the commencement and end of the trial using the Cambridge Neurological Test Automated Battery and an electrophysiological paradigm named event-related potentials. The results presented disclosed a significant improvement in the speed of processing information in the group consuming blueberries compared to the placebo group over the 6-month intervention period. Additionally, the speed of this group's processing was re-established to the level of the reference group, revealing the restoration of cognitive abilities. The most distinct enhancement was noted in participants aged between 75-80 years in the blueberry group.

A Review Article published in 2022 in the journal Molecules found that Depression, a prevalent and debilitating disorder, necessitates novel treatments beyond conventional drugs. Stingless bee honey, rich in antioxidants, emerges as a potential antidepressant candidate, explored comprehensively through monoamine, inflammatory, and neurotrophin hypotheses. This comprehensive review delves into the urgent need for safer and more effective depression treatments, considering the limitations of conventional drugs. The focus is on Stingless Bee Honey (SBH), recognized for its high antioxidant content, and its potential as an antidepressant is explored through the lenses of the monoamine, inflammatory, and neurotrophin hypotheses. Stingless bee honey's potential as an antidepressant is examined in the context of its antioxidant richness, offering a new avenue for addressing depression beyond conventional drug approaches. The review highlights the importance of exploring alternative medicines, such as SBH, for safer and more efficacious depression treatments.

A Network Pharmacology published in 2022 in the journal Natural Product Communications found that Combining traditional Chinese medicine may offer potential therapeutic value in treating both Alzheimer's disease and major depressive disorder simultaneously. Researchers leveraged network pharmacology and molecular docking technology to identify the effect of traditional Chinese medicine and its multitarget components for treating Alzheimer's disease and major depressive disorder. They analyzed 234 TCM prescriptions for major depressive disorder, identifying the top 10 most commonly used herbs, reflecting 198 active ingredients. They then did comparative analysis for prospective ingredient targets related to both disorders. The analysis included exploring common and key targets and representative compounds for effective treatment. The combination of Xiangfu (Cyperi Rhizoma), Gancao (Licorice) and Chaihu (Radix Bupleuri) constituted the major component of representative ingredients that were analyzed. The results yielded the identification of 30 common targets, 9 key targets, and 7 representative compounds relevant to both disorders. Their findings revealed these common targets were essential to regulate multiple pathways linked to both disorders, emphasizing the potential for a cohesive treatment approach. Furthermore, molecular docking studies unveiled the binding affinity of several natural chemicals, including quercetin, kaempferol, β-sitosterol, stigmasterol, isorhamnetin, naringenin, and 8-isopentenyl-kaempferol, with key prospective targets. This suggests that a TCM combination could provide therapeutic advantages in treating both Alzheimer's disease and major depressive disorder.

A Review Article published in 2022 in the journal Frontiers in Pharmacology found that Xiao Yao San has potential as an effective and safe alternative treatment for depression, offering multiple mechanisms of action for its antidepressant effects. The article discusses the use of Xiaoyaosan, a traditional Chinese medicine formulation, in the treatment of depression. It reviews recent evidence from animal and clinical studies, highlighting the pharmacological mechanisms and effective components involved in the antidepressant effects of Xiaoyaosan. The review explores various factors such as neurotransmitters, neuroplasticity, inflammatory response, gut-brain axis, oxidative stress, and autophagy that contribute to its therapeutic effects. The article emphasizes the potential of Xiaoyaosan as an alternative therapy for depression and provides an overview of its mechanisms of action.

A Systematic Review published in 2022 in the journal Frontiers in Neuroscience found that Chinese herbal medicine shows promising and safe outcomes in relieving functional dyspepsia symptoms and associated psychological disorders. The methodology for this research involved a comprehensive search across various libraries and databases, such as PubMed, Embase, Cochrane Library, Web of Science, and various Chinese data sources, seeking randomized controlled trials where functional dyspepsia was treated with Chinese herbal medicine. The aim was to assess the efficacy and safety of this type of treatment for functional dyspepsia. Two researchers independently conducted each stage of the process, from searching the sources, screening the documents, extracting data, and assessing risk biases within the included studies. They used RevMan 5.4 software to do a meta-analysis of the selected research materials. The discussion of their findings showed that treatment with Chinese herbal medicine significantly alleviated the symptoms of functional dyspepsia, compared to both a placebo group and a group treated with traditional prokinetic agents and flupentixol melitracen. Patients treated with Chinese herbal medicine reported higher total effective rates and lower total symptom scores, along with smaller depression and anxiety scores. The symptoms of functional dyspepsia, in this case, were improved more successfully with Chinese herbal medicine than with other treatment types, without any significant adverse reactions.

A Systematic Review published in 2022 in the journal Critical Reviews in Food Science and Nutrition found that Vitamin D supplementation, particularly in doses greater than 2,000 IU/day, can help reduce depressive symptoms in adults. In the methodology, a comprehensive database search (including Medline, PsycINFO, CINAHL and The Cochrane Library) was performed to identify English language articles relating to the impact of Vitamin D on depression in adults, published before April 2022. This meta-analysis considered both general and clinical populations and also included studies of individuals suffering from systemic diseases, but excluded studies involving light therapy, co-supplementation (except calcium), and bipolar disorder. During the assessment of the work, the Cochrane risk-of-bias tool (RoB 2) and GRADE standards were employed to appraise the validity of each study. The results revealed a positive effect of Vitamin D on alleviating depressive symptoms. Despite the presence of high heterogeneity within included studies and with the majority having concerns related to risk of bias, it was found overall that Vitamin D supplementation, particularly when administered at doses about 2,000 IU/day, could serve as a valuable solution in reducing depressive conditions. This offers an interesting angle for mental health treatment, suggesting the supplement could be a useful addition to standard therapeutic procedures for clinical depression.

A Randomised Controlled Trial published in 2022 in the journal Frontiers in Pharmacology found that Modified Xiao Chai Hu Decoction combined with mirtazapine shows superior effectiveness in treating persistent depressive disorder compared to traditional Chinese medicine alone. For the study, patients from the Naval General Hospital diagnosed with persistent depressive disorder were selected and divided into two groups. One group received modified Xiaochaihu Decoction only, while the other group was treated with a combination of modified Xiaochaihu Decoction and mirtazapine. To track progress, measurements were taken using the self-rating depression scale and the traditional Chinese medicine scale at the beginning of treatment, and again after a period of 12 weeks. Moreover, an account of any adverse reactions was also kept. The study results indicate the total effective rate was significantly higher in the combined group compared to the control group. It was also found that while post-treatment scores of the depression scales were lower in both groups, the difference between the groups was not statistically significant. However, the combined group reported higher improvement rates for symptoms like insomnia, bitter taste, languid, and belching/anorexia. An increased frequency of adverse events was also noted in the combined group.

A Systematic Review published in 2022 in the journal Frontiers in Pharmacology found that Chinese herbal medicine was effective in treating coronary heart disease patients with anxiety or depression, particularly in improving angina pectoris, and its active compounds could act on the pathological targets of CHD, anxiety, and depression. The meta-analysis of 32 studies found that Chinese herbal medicine (CHM) was more effective in treating anxiety and depression in patients with coronary heart disease (CHD) compared to control groups, and the efficacy of CHM was similar to Western medicine. Additionally, CHM was shown to improve angina stability in CHD patients with anxiety or depression better than control and Western medicine groups. The study identified the main underlying mechanisms to involve anti-damage/apoptosis, anti-inflammation, antioxidative stress, and maintaining neurotransmitter homeostasis, with certain herbal compounds being most related to CHD, anxiety, and depression.

A Randomised Controlled Trial published in 2022 in the journal Explore: The Journal of Science & Healing found that Inhalation aromatherapy using lavender and chamomile essential oils effectively reduces depression, anxiety, and stress levels in community-dwelling older adults. From a methodological perspective, the researchers adopted a three-armed, parallel, randomized, and controlled trial design. A total of 183 participants were enrolled in the study and were randomly divided into three groups: lavender, chamomile, and control group with equal numbers in each. The individuals in the experimental groups were given three drops of 1.5% lavender and chamomile essential oils to inhale for 30 consecutive nights, while the control group inhaled distilled water in the same manner. The Depression, Anxiety, and Stress-Scale (DASS) was utilized to collect data both prior to the intervention, directly following the intervention, and a month after the treatment. In terms of the results gathered, there was significant improvement in the depression, anxiety, and stress levels of individuals in the lavender and chamomile groups both immediately and one month after the treatment compared to the control group. This indicates that inhalation aromatherapy utilizing lavender and chamomile essential oils can be efficacious in reducing mental health issues among older adults residing in the community.

A Systematic Review published in 2022 in the journal Frontiers in Psychiatry found that Acupuncture can be a safe and effective alternative therapy to conventional drugs for improving sleep quality and relieving symptoms in patients with active depression. The research methodology involved a systematic review of randomized controlled trials focusing on the effect of acupuncture on depression-related insomnia. These studies were identified from seven different databases, dating up until December 2021. The papers included compared acupuncture to controls (waiting list or placebo/sham acupuncture) and conventional treatments (Western pharmacotherapy and/or cognitive-behavioral therapy) either alone or in combination with acupuncture. The analysis followed Cochrane criteria and encompassed a total of 21 trials, including 1,571 participants. Regarding results, it was found that acupuncture significantly reduced severity metrics of sleep quality and depression for patients who have active depression, compared with placebo-acupuncture. When contrasted with standard care (antidepressants and/or sleeping aids), acupuncture led to improvements in sleep quality and depressive symptom scores. However, for those suffering from the lingering symptoms of past or partially treated depression, the therapeutic benefits of acupuncture were minor and not statistically noteworthy. Unfortunately, no studies were found to review acupuncture's efficacy compared to cognitive-behavioral therapy or its potential synergistic effect when used concurrently.

A Systematic Review published in 2022 in the journal Evidence-Based Complementary and Alternative Medicine found that Xiao Yao San, alone or combined with anxiolytics, assists in better improvement and safety in treating anxiety disorders compared to anxiolytics alone. The methodology involved a systematic search on PubMed, Cochrane Library, EMBASE, Web of Science, and several Chinese databases for all randomized control trials (RCTs) that have evaluated the use of XYS for treating anxiety disorders until November 2021. The studies were independently screened, and data were extracted by two investigators who also assessed the risk of bias in the selected trials using RevMan5.3 software. The meta-analysis result shows that the use of XYS, either on its own or together with anxiolytics, showed better improvements in anxiety-related symptoms and fewer adverse drug reactions compared to treatment with anxiolytics only. This suggests that XYS, whether used alone or in conjunction with anxiolytic agents, appears to offer a more effective and safer treatment option for anxiety disorders.

A published in 2022 in the journal Journal of Ethnopharmacology found that Xiang Fu, a traditional Chinese herbal medicine, shows significant antidepressant effects. The study reviewed the major antidepressant mechanisms and clinical applications of Cyperi Rhizoma, known as CR. It aimed to evaluate the pharmacological effects and the chemical compositions associated with these effects. The authors underwent an extensive literature search using "Cyperus rotundus L." as the search term across multiple electronic databases including Web of Science, ScienceDirect, and PubMed. In discussing the results, the researchers found that CR has broad application in alleviating symptoms related to stagnation of Qi, such as issues with the liver, stomach, and bowels, common in different countries. They identified the effective constituents of CR, including Aqueous extract, EtOH extract, essential oil, total oligomeric flavonoids, and five other extracts. These exhibited various pharmacological activities, such as antibacterial, antioxidant, neuroprotective, antihemolytic, and anti-inflammatory effects. Notably, specific components like α-cyperone and nootkatone showed antidepressant effects. Through synthesizing this scientific information, they concluded that CR holds potential as a herbal medicine to develop antidepressant drugs with fewer side effects.

A Review Article published in 2022 in the journal Current Neuropharmacology found that Acupuncture could help manage different types of depression by increasing neuroplasticity, decreasing brain inflammation, and reducing side effects of conventional antidepressant treatment. The study under review examines the possible mechanisms and clinical effectiveness of acupuncture in the treatment of different forms of depression. To do this, the researchers examined existing studies and evidence involving both human patients and animal models. A significant aspect of the investigation involved assessing how acupuncture influences neuroplasticity within the hippocampus and neural networks, along with probing the role of this non-pharmaceutical therapy in modulating brain inflammation, which had potential implications for alleviating depressive disorders. The discussions of the results indicated that acupuncture showed considerable promise in the relief of primary depression, especially in milder cases. It was also found useful in the management of post-stroke depression, pain-related depression, and post-partum depression. The study noted positive outcomes both when acupuncture was offered as a stand-alone treatment, and when combined with conventional pharmacological treatments. It was observed that the combination of acupuncture and anti-depressant drugs not only improved primary and secondary depressive symptoms but also managed to reduce the side-effects often associated with medication regimens, which are frequent contributors to high dropout rates in pharmacological treatments.

A Experimental Study published in 2022 in the journal Molecules found that Saffron and its bioactive molecules, notably crocins, have been found to be as effective as common antidepressants in treating depression disorders. The methodology of the research centered on the incredible therapeutic properties of saffron, more specifically its bioactive molecules known as crocins. These molecules were singled out as they have shown a capacity to inhibit monoamine oxidase type A and B. The researchers also conducted experiments with saffron petal extracts, observing their impact on contractile response in electrical field stimulation. There were further investigations into saffron's ability to inhibit the reuptake of monoamines, display -methyl-d-aspartate antagonism, and enhance brain-derived neurotrophic factor signaling. The discussion of the results highlighted the effectiveness of saffron and its crocins in treating depressive disorders. From several experimental studies, it became apparent that saffron and crocins might perform similarly to fluoxetine and imipramine, both widely accepted antidepressant drugs. As such, the paper suggests that these natural elements found in saffron could offer an alternative treatment method for depression. The limitations, however, as highlighted in the study, were issues surrounding stability and delivery of the herbal treatment.

A Randomised Controlled Trial published in 2022 in the journal Journal of Diabetes Research found that Vitamin D supplementation effectively improves depressive symptoms in women with type 2 diabetes and low vitamin D levels, regardless of the dose administered. In the study, a double-blind randomized active comparator-controlled trial was performed. Female participants with significant depressive symptoms, as indicated by the Center for Epidemiologic Studies Depression scale, received weekly oral vitamin D supplements: a group received a higher dose (50,000 IU), while the control group received a lower dose (5,000 IU). These doses were taken over the course of 6 months, and participants' vitamin D and depression levels were evaluated at baseline, at the 3-month point, and at the end of the study. The improvement in depressive symptoms over the course of the study was significant, irrespective of the supplement dose given. There was no discernible difference between the depression scores of those who received the higher dose compared to those who received the lower dose. This remained true when considering women with moderate baseline depressive symptoms. However, among women with severe depressive symptoms at the outset, both groups showed similar improvements in their follow-up depression scores. The dose administered did not affect the significant time-related decrease in depressive symptoms.

A Network Pharmacology published in 2022 in the journal Annals of Medicine found that The Gui Zhi-Shao Yao herb pair in traditional Chinese medicine potentially treats chronic pain, anxiety, and depression through interactions with nine key targets. The methodology in this research utilised network pharmacology to explore the active components of the "Gui Zhi-Shao Yao" herb pair and their possible targets. Initially, 15 active compounds were identified through a series of analysis which revealed about 130 potential targets. By considering the intersections between the targets of the "Gui Zhi-Shao Yao" herb pair and chronic pain, anxiety disorder, and mental depression, nine vital targets were identified and listed in order of importance. The results discussion revealed that the "Gui Zhi-Shao Yao" herb pairing acted on the nine identified key targets to alleviate chronic pain, anxiety, and depression. Gene ontology and pathway analysis demonstrated that there were 11 primary pathways, including AGE-RAGE signalling pathway, IL-17 signalling pathway, and TNF signalling pathway. These pathways appear to be actively involved in the pathological processes, providing a holistic understanding of how the "Gui Zhi-Shao Yao" herb pair functions therapeutically.

A Animal Study published in 2022 in the journal Plants found that The traditional Chinese medicine Gan Mai Da Zao Tang may lessen depressive behaviors in rats, likely through licorice increasing serotonin transporter and brain-derived neurotrophic factor signals in the hippocampus. This study experimentally examined the antidepressant impacts of Gan-Mai-Da-Zao (GMDZ), a Chinese traditional medicine that contains blighted wheat, licorice, and jujube. The researchers used an unpredictable chronic mild stress model in rats, some of whom received an injection with p-chlorophenylalanine to generate a chemical model for depression. The investigators employed behavioral tests, including forced swim tests, open field tests, and sucrose preference tests, to evaluate the chronic influence of GMDZ. The oral application of GMDZ over 21 days considerably eased depressive behaviors in rats induced by either the unpredictable chronic mild stress or p-chlorophenylalanine. The treatment increased the expression of the serotonin transporter and brain-derived neurotrophic factor in the hippocampus in the rats with depression. However, rats provided with a similar herbal mixture that did not include licorice showed a significantly worse response, suggesting that licorice may play an essential role in the efficacy of GMDZ in combatting depression-like behaviors.

A Systematic Review published in 2022 in the journal Medicine found that High prevalence of insomnia, anxiety, and depression among perimenopausal women, emphasizing the importance of exploring acupuncture as a potential green therapy for effectively addressing these interconnected issues. This passage discusses the prevalence of insomnia among perimenopausal women, its association with anxiety and depression, and the potential of acupuncture as a green therapy for treating these issues. The passage outlines the objectives and methods of a systematic review aiming to evaluate the efficacy of acupuncture in improving sleep quality and alleviating anxiety and depression in perimenopausal women, highlighting the need for safer alternatives to conventional medications and the significance of such a study.

A Randomised Controlled Trial published in 2022 in the journal The Journal of Nutritional Biochemistry found that Dark chocolate exerts prebiotic effects and may improve negative emotional states via the gut-brain axis. To assess the association between the mood-altering effects of dark chocolate and the gut microbiota, we performed fecal 16S rRNA sequencing analysis for the DC85 and CON groups. Gut microbial diversity was significantly higher in DC85 than CON (P<.05). Blautia obeum levels were significantly elevated and Faecalibacterium prausnitzii levels were reduced in DC85 compared to CON (P<.05). Furthermore, we found that the observed changes in negative affect scores were negatively correlated with diversity and relative abundance of Blautia obeum (P<.05).

A Meta-Analysis published in 2022 in the journal Pharmacological Research found that Saffron intake might aid in reducing depressive symptoms but it should not be regarded as an exclusive solution for treating depression. This study conducted a comprehensive umbrella meta-analysis of previously published research studies to evaluate the effect of saffron on depression. The researchers collected the relevant studies from various acclaimed international databases like PubMed, Scopus, EMBASE, Web of Science, and the Cochrane Central Library, up until June 2021. All gathered research was based on the effects of saffron on depression. A random-effects model was employed to conduct the meta-analysis and additional analyses, which included subgroup and sensitivity examination. The meta-analysis consisted of seven individual studies altogether. The evaluations displayed that the consumption of saffron led to an observable decrease in Beck's Depression Inventory (BDI) scores, indicating a reduction in depressive feelings. However, the Hamilton Depression Rating Scale (HAMD) scores didn't exhibit any significant change post saffron consumption. Some other mixed scores also remained unchanged. Thus overall, it was deduced that while saffron intake might help alleviate depression, it can't solely be relied upon for effectively treating this mental disorder.

A Randomised Controlled Trial published in 2021 in the journal Journal of Trauma Nursing found that Auricular acupressure may be a safe and effective technique for reducing burnout and secondary traumatic stress in healthcare workers. In this prospective randomized trial with an open, parallel-group design, participants were randomized to receive one of three interventions: auricular acupuncture, auricular seed acupressure, or auricular massage. Interventions took place over a period of 3 weeks at a 334-bed Level II pediatric trauma center. Using a pre-/posttest design, the researchers analyzed self-reported scores from the State-Trait Anxiety Inventory, the Professional Quality of Life scale, and the Caring Ability Inventory. The study found that auricular seed acupressure was associated with a reduction in burnout and secondary traumatic stress. Importantly, this effect remained even after adjusting for individual pretest scores. Attempts at achieving significant effects on anxiety levels, professional quality of life, and caring ability, however, did not yield any significant improvement. Overall, the data suggest that auricular acupressure is a very effective strategy for reducing work-related stress among health care staff.

A Cohort Study published in 2021 in the journal Frontiers in Aging Neuroscience found that Stroke patients who received acupuncture had a lesser risk of insomnia across various demographic and medical variables. The study data was derived from the case database of a Chinese hospital, featuring stroke patients diagnosed between 2010 and 2019. These patients were sorted into two groups: one which received acupuncture and one which did not. The sorting was performed using a propensity score matching technique. Comparisons were made between the two groups using the incidence of insomnia as the primary indicator, with Cox regression analysis and the Kaplan-Meier method serving as the main analytical tools. The results indicated that stroke patients who underwent acupuncture treatments were less susceptible to insomnia as compared to counterparts who didn't receive acupuncture treatment. This decrease in the incidence of insomnia was observed across various categories such as genders, age groups, stroke types and stroke locations, with the acupuncture group displaying a significantly lesser cumulative incidence of insomnia.

A Animal Study published in 2021 in the journal Oxidative Medicine and Cellular Longevity found that Pumpkin extract exhibits potential antidepressant effects similar to fluoxetine and ameliorates biochemical and structural changes in rat brains resulting from chronic stress. The researchers used forty male albino rats, split into four different groups: a negative control group, a chronic unpredictable mild stress (CUMS) group, a fluoxetine-treated group, and a pumpkin-treated group. These rats were exposed to CUMS for 28 days, with the treatments applied during the last 14 days of this exposure period. After these 28 days, the scientists evaluated the behavioral, biochemical, and histopathological alterations in these rats. The application of pumpkin extract significantly reduced markers of stress and inflammation, while increasing antioxidant levels. Additionally, the extract helped reduce structural damage in the hippocampal region of the brain caused by exposure to CUMS. These effects were comparable to those observed by administering fluoxetine, a conventional antidepressant.

A Randomised Controlled Trial published in 2021 in the journal Complementary Therapies in Medicine found that Lavandula angustifolia essential oil inhalation seemed to enhance overall sleep patterns, quality, and efficiency in postmenopausal women with insomnia. Methodology: 35 postmenopausal women, clinically diagnosed with insomnia, were recruited and divided into two groups - an Aroma Group and a Placebo Group - for a double-blind, randomized controlled trial. Over 29 days, participants in the Placebo Group inhaled sunflower oil, while participants in the Aroma Group inhaled lavender oil. Both groups were given sleep hygiene guidelines before embarking on the trial and received follow-up on a weekly basis. Evaluations were performed both pre- and post-intervention. Discussion of Results: No significant differences were noted between the two groups in terms of sleep quality. However, certain tendencies were observed. Aroma Group participants showed a noteworthy reduction in the time taken to fall asleep, depression levels and postmenopausal symptoms such as hot flashes. Moreover, polysomnography data showed increased sleep efficiency in comparison to initial levels. The improvement in sleep quality over time was observed in both groups, indicating that sleep hygiene instruction and weekly follow-ups played a significant role in influencing sleep patterns and quality.

A Review Article published in 2021 in the journal Trends in Food Science & Technology found that Coconut oil has potential therapeutic value in treating Alzheimer's disease by suppressing neuro-inflammation, reversing neurodegeneration, and inhibiting secretion of harmful peptides. The methodology of this study hinges on investigating the impact of coconut oil-derived medium chain fatty acids (MCFAs) on brain glucose metabolism, which is linked to Alzheimer's Disease (AD). These MCFAs rapidly metabolize into ketone bodies, possibly providing alternative energy for cerebral tissue. This research evaluates the recent findings on the role of coconut oil in mitigating AD symptoms, including its dietary effects on reducing neuro-inflammation, reversing neurodegenerative processes, and inhibiting the secretion of amyloid β peptides, which contribute to AD. The results of the investigation reveal a promising correlation between coconut oil and the amelioration of AD symptoms. The effectiveness of coconut oil is believed to be due to its ability in enhancing cell survival pathways, suppressing neuro-inflammation, and reversing neurodegeneration. Coconut oil also proves useful in preventing the secretion of harmful amyloid β peptides, as seen in animal models and human clinical trials. These multi-pronged biochemical effects underline the immense therapeutic potential of coconut oil in treating AD.

A Systematic Review published in 2021 in the journal Evidence-Based Complementary and Alternative Medicine found that The comprehensive evaluation results show that scalp acupuncture is effective in treating insomnia. A total of 21 studies were included in this study, and a total of 1606 cases were included. The comprehensive evaluation results show that scalp acupuncture is effective in treating insomnia. Compared with the control group, scalp acupuncture can significantly improve the effective rate of treating insomnia. The PSQI score subgroup analysis showed that the PSQI score of the head was significantly better than that of the drug and blank group, but there was no significant difference from other acupuncture methods. Sensitivity analysis showed that scalp acupuncture ameliorates the PSQI score better, but excluding any item had high heterogeneity. Meta regression analysis of PSQI score according to different intervention measures in the control group showed that the difference of intervention measures in the control group was the source of heterogeneity. In terms of adverse events, the scalp acupuncture group had no adverse events, which was significantly better than the control group. Based on this study, we found that scalp acupuncture is effective and safe in the treatment of insomnia.

A Systematic Review published in 2021 in the journal Critical Reviews in Food Science and Nutrition found that Cocoa-rich products consumption can improve mood and affect in the short term. The study carried out a systematic review and meta-analysis in line with PRISMA guidelines to ascertain the effects of cocoa-derived food on depressive and anxiety symptoms, as well as positive and negative affect. Potential sources were found on Web of Knowledge and PsycINFO until April 3, 2020. Out of 761 documents screened, nine studies were picked. Two trials were involved in examining the long-term impact (>1 week) of cocoa consumption, two reviewed the short-term effects (3 days), and five studies were conducted in acute conditions (single administration). The results indicate that cocoa-rich products had a significant overall effect on reducing depressive and anxiety symptoms. There was also significant improvement in both positive and negative affect. The effect size in all meta-analyses was medium, while the heterogeneity was low. Despite these promising outcomes, the conclusions must be cautiously interpreted due to the short duration of the trials and the limited number of participants and studies included in the meta-analyses.

A Randomised Controlled Trial published in 2021 in the journal Physiology & Behavior found that Combining resistance training with saffron supplementation enhances happiness levels and increases dopamine and serotonin concentrations more than resistance training alone. In this research, untrained young males were divided into two groups, one receiving resistance training coupled with saffron supplementation (150 mg pill of pure saffron post-workout and at a similar time on rest days), while the other received resistance training with a placebo (dextrose pill). For a period of six weeks, whole-body supervised resistance training was performed four times per week with three sets using 60-70% of their single repetition maximum. Various markers implicated in depression and happiness levels were assessed before and after this period. In terms of results, substantial increases in various markers including Anandamide, Arachidonoylglycerol, dopamine, and beta-endorphin were noticed within the group combining resistance training with saffron supplementation, yet no such changes were evident within the group who took the placebo. Compared to the placebo, the saffron group also experienced more significant improvements in happiness levels. Moreover, serotonin levels increased in both groups but were greater in the saffron-supplemented group, while tryptophan concentrations remained unchanged. Notably, both groups noted significant boosts in muscular endurance; these changes were greater with saffron supplementation.

A Review Article published in 2021 in the journal Journal of Ethnopharmacology found that Pomegranate has a variety of phytochemicals which possess wide-ranging activities including antioxidant, antimicrobial, anti-oncogenic properties, and resistance to cerebrovascular disease. The paper presents an overview of the traditional medicine theories of pomegranate, its origin and spread along the Silk Road, ethnopharmacological uses, chemical compositions, pharmacological activities, toxicology, and the involved pathways. Information was collected from various published sources like ancient and modern texts, medicinal plant monographs, pharmacopoeias and diverse electronic databases. Pomegranates, being widely cultivated in Central Asia and having spread throughout China via the Silk Road, have had significant usage in many traditional medical systems over time. They are identified to contain a vast array of phytochemicals like tannins, organic acids, flavonoids, alkaloids, and volatile oils. These compounds are observed to have extensive activities such as antioxidant, antimicrobial and anti-oncogenic properties, and also provide resistance to cerebrovascular disease. The research additionally presents a summary of the promising pharmacological pathways linked with pomegranate.

A Randomised Controlled Trial published in 2021 in the journal Reproductive BioMedicine & Society Online found that Women receiving IVF perceived that acupuncture or sham acupuncture gave them a psychological advantage through increased relaxation, reduced psychological stress, and enhanced well-being and self-efficacy. In this qualitative study, participants reported that compassionate care and an opportunity to rest during IVF, and especially following embryo transfer, had an emotionally important effect. All women in the trial underwent the same procedural practices which involved bed rest during needling, among other comforts. Some women described benefitting purely from this opportunity to rest quietly in a supportive environment amidst the maelstrom of IVF. There was also recognition that this ‘oasis’, albeit brief, was an important time for allowing the meaning of having an embryo transferred to ‘soak in’, and presented an oppportunity to ‘be in the moment’.

A Systematic Review published in 2021 in the journal Annals of General Psychiatry found that Acupuncture therapy aimed at reducing anxiety in patients with generalised anxiety disorder has certain beneficial effects compared to controls. Twenty RCTs were included in this systematic review and meta-analysis. All included studies were designed for patients with generalised anxiety disorder (GAD), and 18 studies were published in Chinese. Egger’s test showed that the asymmetry of the funnel plot in all studies was not significant. The meta-analysis of anxiety symptoms showed that acupuncture was more effective than the control condition, with a standard mean effect size of − 0.41, and that acupuncture intervention showed good tolerance and safety in the treatment of anxiety disorder.

A Systematic Review published in 2021 in the journal Physical Activity and Health found that All schools of Tai Chi chuan can improve the mental health of the elderly. Tai Chi's potential mechanisms include reducing anxiety, relieving depression and stress, enhancing pulmonary and cardiovascular function, enhancing immunity and improving quality of life.

A Review Article published in 2020 in the journal Molecules found that Shaded gardening of Japanese matcha creates high-quality tea with unique compounds that can boost physical and mental health. This study reviewed and compiled health benefits of matcha tea, a type of powdered green tea grown traditionally in Japan with plants shaded during growth. This shading process promotes the synthesis and accumulation of unique biologically active compounds, which includes theanine, caffeine, chlorophyll, and a variety of catechins, with matcha offering a condensed source of these elements. The review indicated that matcha is considered the highest quality tea due to its distinctive chemical composition and prized flavor. In discussing the results, a major conclusion reached was that matcha tea has effective health-promoting attributes due to the tea's high content of antioxidant and anti-inflammatory substances. Such benefits have largely been credited to its significant proportion of catechins - a type of phenolic compound beneficial to human health. The high antioxidant potential of the tea and its subsequent ability to help prevent various diseases and support cognitive function underscores the value in regular consumption of matcha for not only physical health, but also mental health.

A Randomised Controlled Trial published in 2020 in the journal Nature and Science of Sleep found that Ten sessions of electroacupuncture can improve the sleep quality of patients with insomnia without serious adverse effects. Results of the current trial provide supportive evidence that electroacupuncture can be an effective, safe, and well-tolerated non-pharmacological intervention for insomnia, using validated placebo control and validated subjective questionnaires. Further long-term studies with objective sleep measures are needed for a more definitive conclusion.

A Cohort Study published in 2020 in the journal Frontiers in Aging Neuroscience found that Depressed patients who received acupuncture treatment showed a significantly lower risk of developing Parkinson's disease. The study was retrospective in nature and was based on data sourced from Taiwan's National Health Insurance Research Database. An equal number of patients (9,189), with and without acupuncture treatment, were selected from the total 48,981 patients newly diagnosed with depression between 2000 and 2012. These study participants were matched 1:1 using the propensity score method. The incidence of Parkinson's disease in these two groups was compared using the Kaplan-Meier method and the difference was examined with a log-rank test. The severity of depression and specific acupoints used were not indicated. The results indicated a significantly lower risk of developing Parkinson's disease in patients who had undergone acupuncture treatment. Differences in age, sex, insurance amount, geographic region, urbanization levels, comorbidities, and drugs were taken into account. The cumulative effect was such that the incidence was significantly lower in the acupuncture cohort as compared to the non-acupuncture cohort.

A Systematic Review published in 2020 in the journal Neuropsychiatric Disease and Treatment found that Acupuncture is associated with a reduction in the risk of depression during long-term follow-up in patients with trigeminal neuralgia. In total, 776 patients with newly diagnosed trigeminal neuralgia in each cohort with similar baseline characteristics were enrolled in the study. The acupuncture cohort had a reduced risk of depression compared to the non-acupuncture cohort. Kaplan–Meier analysis also revealed that the cumulative incidence of depression was significantly lower in the acupuncture cohort during the 13-year follow-up period. In particular, the beneficial effect of acupuncture was a decrease in the risk of depression among TN patients aged 50– 69 years who had also used carbamazepine.

A Review Article published in 2020 in the journal Clinical Psychopharmacology and Neuroscience found that Omega-3 polyunsaturated fatty acids supplementation during the prenatal and perinatal period could have a protective effect on neurodevelopmental disorders including ADHD, ASD, and MDD in youth. The research implemented supplementation of omega-3 polyunsaturated fatty acids also known as Omega-3 PUFAs, in different quantities and durations to youth with attention deficit hyperactivity disorder (ADHD), major depressive disorder (MDD) and autism spectrum disorder (ASD). This was carried out based on suggested dosage and duration from various randomized controlled trials and systemic literature reviews. It was observed that omega-3 PUFAs were essential nutrients not just for physical health but also for mental health, more so during the prenatal and perinatal stages of development. The results demonstrated that clinical symptoms improved in youth with ADHD, MDD and ASD after they were supplemented with Omega-3 PUFAs, especially in cases where there was high inflammation or low baseline Omega-3 index present. The research showed very promising evidence that Omega-3 PUFAs had positive effects on lethargy and hyperactivity symptoms in ASD. There was also an inclination that Omega-3 PUFAs levels and inflammation could be potential markers for treatment response in ADHD and MDD.

A Review Article published in 2020 in the journal Frontiers in Aging Neuroscience found that Acupuncture appears to be a promising complementary treatment for Alzheimer's disease, according to findings from systematic reviews and meta-analyses. The study analysed the role of acupuncture as a complementary treatment for Alzheimer's disease by perusing systematic reviews and meta-analyses using data from eight electronic databases. The researchers employed a variety of tools such as the Assessing the Methodological Quality of Systematic Reviews 2, Risk of Bias in Systematic Reviews tool, Preferred Reporting Items for Systematic Reviews and Meta-Analyses, and the Grading of Recommendations, Assessment, Development, and Evaluation to determine the quality of methodology, risk of potential bias, and quality of the evidence. A total of eleven systematic reviews and meta-analyses met the necessary criteria for inclusion in this study. The results, despite indicating that acupuncture may show promise as a complementary treatment for Alzheimer's disease, all rated critically low in quality when assessed with the tools employed. Some methodological weaknesses remained, particularly pertaining to the protocol and registration, search strategy, risk of bias, additional analyses, and funding. Only a small portion of the reviews exhibited a low risk of bias. There was no high-quality evidence found, but moderate-quality evidence was provided for seven outcomes. The risk of bias in the original trials seemed more prevalent than inconsistency, imprecision, and publication bias.

A Randomised Controlled Trial published in 2020 in the journal Nutrients found that Daily supplementation of Matcha Green Tea Powder is found to enhance cognitive functions in elderly women. The research performed a randomized, double-blind, placebo-controlled trial over a period of 12 weeks. The involvement of 61 participants who were community-dwelling elderly people was arranged, and these participants were randomly assigned to either a test group receiving a daily drink containing 3 grams of Matcha Green Tea Powder or a placebo group. Assessments of their cognitive function changes were made using a psychometric test battery. Also, the participants' daily food intake was monitored and recorded using a Brief-type Self-administered Diet History Questionnaire. The results clearly indicated substantial enhancement in cognitive functions in women who were part of the active test group. It was observed in the Montreal Cognitive Assessment (MoCA) scoring scheme. An interesting pattern that came up in the dietary analysis was the significant inverse correlation between consumption of vitamin K in everyday food apart from test drinks and a change in MoCA. Overall, the study indicates that regular intake of Matcha Green Tea Powder can have protective effects against cognition decline, particularly in elderly women residing in the community.

A Review Article published in 2020 in the journal Scientific African found that Pumpkin seeds carry bioactive compounds with potential benefits such as antidiabetic, antidepressant, antioxidant, antitumor, and cytoprotective activities, also aiding in microbiological infections and specific organ disorders. The methodology utilised an in-depth literature review, compiling evidence-based data from various electronic databases such as ScienceDirect, ResearchGate, PubMed, Scopus and Google Scholar up until January 2020. The focus of the gathered literature was the potential use of pumpkin seeds as a functional food ingredient and assessing the associated biological mechanisms of the bioactive compounds within the seeds. Pumpkin seeds, despite being small, are rich in a wide variety of beneficial nutrients such as amino acids, phytosterols, unsaturated fatty acids, phenolic compounds, tocopherols, cucurbitacins and valuable minerals. The bioactive compounds found within these seeds have shown multiple promising activities. They possess anthelmintic, antidiabetic, antidepressant, antioxidant, antitumor and cytoprotective properties. Additionally, they demonstrate potentials for addressing microbiological infections and specific disorders related to liver and prostate. The compiled literature strongly suggests that pumpkin seeds can be used as both a traditional and functional food ingredient due to the wide array of health benefits they offer.

A Experimental Study published in 2020 in the journal Frontiers in Pharmacology found that Jujube seed extract has been found to primarily reduce anxiety by regulating the GABAergic and serotonergic synapse pathways, specifically modulating GABRA1, HTR1A, and HTR2A. The research relied on a system biology method supported by Ultra Performance Liquid Chromatography Quadrupole Time of Flight Mass Spectrometry (UPLC-Q-TOF/MS) and Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR). Initially, 35 phytochemicals were identified from the Jujube seed extract, which related to 71 anxiolytic targets. Further investigations, including protein-protein interaction, gene cluster, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analyses, were conducted to identify the anxiolytic mechanisms of the extract. The results highlighted that the main anxiolytic mechanisms of the Jujube seed extract were linked to the regulation of serotonergic and GABAergic synapse pathways. The extract's impact on the mRNA expressions of multiple gamma-aminobutyric acid type A (GABA) and serotonin (5-HT) receptors subtypes was verified in human neuroblastoma cells. Surprisingly, the extract (250 μg/mL) not only amplified the mRNA level of GABRA1 and GABRA3 alongside HTR1A, HTR2A, and HTR2B in untreated cells but also suppressed the overexpressed mRNA of GABRA1, GABRA2, HTR1A, and HTR2A in stress-induced cells.

A Systematic Review published in 2020 in the journal Clinical Rehabilitation found that Tai Chi exercise was beneficial for ameliorating physical and mental health of patients with knee osteoarthritis and should be available as an alternative non-pharmacological therapy in rehabilitation programmes. A total of 16 RCTs involving 986 patients with knee osteoarthritis met the established inclusion criteria. The strength of evidence for the main outcomes was low or moderate. The systematic review illustrated the efficacy of Tai Chi exercise in treating and managing knee osteoarthritis. Patients’ outcomes practising Tai Chi exercise were improved significantly, including pain, stiffness, physical function, dynamic balance, physiological and psychological health. No adverse events associated with Tai Chi exercise were reported.

A Randomised Controlled Trial published in 2020 in the journal Journal of Complementary and Integrative Medicine found that Inhalation aromatherapy using Damask rose and lavender essential oils can reduce anxiety and pain in women after they have had a cesarean section. This study was a randomized clinical trial involving 90 mothers who had cesarean sections at a hospital in Jahrom, Iran, in 2017. Prior to intervention, the incidences and severities of pain and anxiety were measured for all participants. The two intervention groups underwent aromatherapy with Damask rose and lavender essential oils. The participants were given cotton balls stained with three drops of these essential oils to inhale from a distance of 10cm for 30 minutes. The control group went through similar procedure but with normal saline. Pain and anxiety levels were assessed using established scales 5 minutes after the specified process. Following the interventions, the two aromatherapy groups experienced significantly different pain and anxiety levels compared to the control group. The results showed no tangible difference between the pain and anxiety levels of those who inhaled lavender oil and those who inhaled Damask rose oil.

A Systematic Review published in 2020 in the journal Evidence-Based Complementary and Alternative Medicine found that In the treatment of chronic pain with depression, acupuncture could not only achieve better clinical efficacy, but also have higher safety compared with conventional mediation therapy. Acupuncture has a promising application prospect due to its unique advantages for the treatment of chronic pain with depression comorbidity, which can be used in patients suffering from some certain chronic pain with depression comorbidity with poorer response to the conventional medication or suffering from serious side effects.

A Systematic Review published in 2020 in the journal Nutrients found that These reports suggest the benefits of a walnut-enriched diet in brain disorders and in other chronic diseases, due to the additive or synergistic effects of walnut components for protection against oxidative stress and inflammation in these diseases. Walnuts contain several components that have antioxidant and anti-inflammatory effects. Animal and human studies from our and other groups suggest that supplementation with walnuts in the diet may improve cognition and reduce the risk and/or progression of mild cognitive impairment and Alzheimer's disease. Furthermore, several animal and human studies have suggested that walnuts may also decrease the risk or progression of other brain disorders such as Parkinson’s disease, stroke, and depression, as well as of cardiovascular disease and type 2 diabetes. Together, these reports suggest the benefits of a walnut-enriched diet in brain disorders and in other chronic diseases, due to the additive or synergistic effects of walnut components for protection against oxidative stress and inflammation in these diseases.

A Experimental Study published in 2020 in the journal Artificial Cells, Nanomedicine, and Biotechnology found that Chrysanthemum morifolium, Naringenin and Apigenin can alleviate depression-like behavior by interfering with specific metabolic pathways. In this study, the researchers decided to evaluate the impact of Chrysanthemum morifolium, Naringenin, and Apigenin on depression-like behaviors instigated specifically by corticosterone. These substances, which are the primary active ingredients in the aqueous extract of C. morifolium and are used in Traditional Chinese Medicine, were analyzed regarding their therapeutic properties for depression. Researchers analyzed behavior and biochemical indicators tied to depression to understand the effects of these substances on a modeled depression scenario. In the discussion of results, the authors highlight that these substances demonstrated antidepressant properties through their interference with certain metabolic pathways. These pathways include tryptophan metabolism, arginine and proline metabolism, citrate cycle, niacin and niacinamide metabolism, phenylalanine metabolism, and alanine, aspartate and glutamate metabolism. The effects were further explained on the basis of material and energy metabolism. Moreover, it was noted that Naringenin could potentially be used as a replacement for Chrysanthemum morifolium with similar beneficial outcomes; while Apigenin paralleled the function of other positive drugs targeting depression.

A Clinical Study published in 2020 in the journal Integrative Cancer Therapies found that Tian Wang Bu Xin Dan can potentially alleviate symptoms of cancer-related insomnia similarly to cognitive-behavioral therapy. In this study, 22 participants were divided equally between a group given Cheonwangbosimdan and a control group who received cognitive-behavioral therapy for insomnia. Participants in the Cheonwangbosimdan group were required to consume the herbal liquid daily and participate in weekly visits for a period of four weeks. Conversely, the control group underwent behavioral therapy sessions 4 times over the same four-week period. The outcomes from these interventions were evaluated using key indices that measured participants' insomnia severity, sleep quality, fatigue, anxiety, and overall performance status. With the focus being on changes observed from the inception of the trial to the end, these measurements were taken at the conclusion of the fifth week. While no significant difference was found between the two study groups, both displayed a positive trend towards alleviating the symptoms of cancer-related insomnia, with anxiety levels markedly lower in the treatment group.

A Systematic Review published in 2019 in the journal Journal of Nursing Research found that Aromatherapy enhances physio-psychological well-being in postpartum women. This systematic review encompassed 15 studies conducted in Iran, England, and the United States, involving 2,131 postpartum participants. The research focused on evaluating aromatherapy's effects on various aspects of postpartum health. Aromatherapy interventions, primarily utilizing lavender and citrus aurantium essential oils, demonstrated positive outcomes. These included relief from nipple fissure pain, improved episiotomy recovery, reduced pain and nausea after cesarean section delivery, and enhanced sleep quality. Additionally, aromatherapy showed potential in positively influencing psychological health, particularly in reducing anxiety. Lavender oil emerged as the most impactful essential oil. While promising, further comprehensive studies are needed to establish aromatherapy as a validated therapy for postpartum women.

A Systematic Review published in 2019 in the journal Evidence-Based Complementary and Alternative Medicine found that Acupuncture therapy is an effective and safe treatment for chronic pain-related insomnia. In our current study, we pooled the data from nine studies involving 944 patients. Our pooled analysis indicated that acupuncture treatment was significantly better than drugs group in improving effective rate and cure rate and in debasing PSQI score and VAS score. In addition, compared with sham acupuncture, manual acupuncture treatment has an advantage in improving the effective rate and reducing the PSQI score, but the two groups have no statistical significance in improving the cure rate. In this meta-analysis, only four studies reported relevant adverse events. The combined data showed no significant difference in adverse reactions between acupuncture group and control group. Therefore, we can carefully recommend that acupuncture is as safe as control group for CPRI. In addition, adverse events were relatively mild, mainly including bruises, soreness, nausea, dizziness, and other discomforts. These adverse events can be effectively avoided by strengthening the aseptic operation specification, and improving the professional ability of doctors. Based on the findings of our included studies, we propose that acupuncture is an effective and safe therapy for patients with CPRI.

A Systematic Review published in 2019 in the journal Current Medical Science found that Acupuncture yielded positive results for Alzheimer's Disease as determined via clinical efficacy rate, Mini-Mental State Examination score, Ability of Daily Living Scale score and Alzheimer’s Disease Assessment Scale-Cognition score. Eight databases were searched for articles published up to and including July 2017, and 13 studies fulfilling the inclusion criteria were identified. The main outcomes assessed were clinical efficacy rate, Mini-Mental State Examination score, Ability of Daily Living Scale score, Alzheimer’s Disease Assessment Scale-Cognition score, Hasegawa’s Dementia Scale (HDS) score, and adverse events. The methodological quality of the articles was assessed using Cochrane’s risk of bias. All the studies compared the efficacy of acupuncture with that of medication, and were published in Chinese journals. Meta-analysis revealed that acupuncture yielded positive results as determined via all the indexes scored except the HDS. Only one of the studies reported adverse events associated with acupuncture and medication. The rate of adverse events in the medication group was 13%. In most of the studies assessed in the current meta-analysis, acupuncture alone was better than conventional western medicines for the treatment of AD.

A Randomised Controlled Trial published in 2019 in the journal Aging found that Our study offers the first evidence of the positive contribution of tea drinking to brain structure and suggests a protective effect on age-related decline in brain organisation. Our study comprehensively investigated the effects of tea drinking on brain connectivity at both global and regional scales using multi-modal imaging data (i.e., functional and structural imaging) and provided the first compelling evidence that tea drinking positively contributes to brain structure making network organization more efficient. Our study suggests that tea drinking is effective in preventing (slowing) or ameliorating cognitive decline and that tea drinking might be a simple lifestyle choice that benefits brain health.

A Systematic Review published in 2019 in the journal Nutrition Reviews found that Saffron shows promising effectiveness in alleviating symptoms of depression and anxiety and augmenting the effects of antidepressants. The research was carried out following the PRISMA guidelines and performed a comprehensive literature review of randomized controlled trials to study the impact of saffron supplementation on symptoms of depression and anxiety. This included both cases where saffron was used alone as a therapy and cases where it was used in conjunction with other treatments. The quality and risk of bias in these studies were evaluated using the Jadad scale. In this analysis, the result of saffron supplementation was compared against placebo and regular pharmacotherapy. It was concluded that using saffron had a notable positive effect in relieving symptoms of depression and anxiety when compared with a placebo. Additionally, it was found that saffron also demonstrated a sizeable positive effect when used alongside antidepressants in treating depressive symptoms. Nonetheless, the Egger's regression test pointed out evidence of publication bias in this area of study.

A Meta-Analysis published in 2019 in the journal Phytotherapy Research found that Chamomile has demonstrative positive effects on generalized anxiety disorders and sleep quality, but exhibits minimal impact on state anxiety and insomnia. The methodology of this study involved rigorous systematic review and meta-analysis across multiple databases, including PubMed, Science Direct, Cochrane Central, and Scopus. The aim was to determine the efficacy and safety of chamomile for managing state anxiety, generalized anxiety disorders, sleep quality and insomnia in humans. Relevant randomized control trials were retrieved, yielding a total of 12 trials used for this study. Statistical analyses were performed with the meta package of R statistical software version 3.4.3 and RevMan version 5.3. The results indicated that chamomile had a significant positive effect on generalized anxiety disorders (GAD) and improved sleep quality. Improvements in GAD were observed after 2 and 4 weeks of chamomile treatment. However, no significant effects were noted in the treatment of state anxiety or insomnia. Mild adverse events were reported in three trials. In conclusion, chamomile was determined to be effective and safe for treating GAD and improving sleep quality, but showed less impact on state anxiety and insomnia.

A Review Article published in 2019 in the journal Frontiers in Psychiatry found that Evidence indicates that acupuncture treatment may be of benefit in several neuropsychiatric disorders, including depression, anxiety, schizophrenia, and Alzheimer's Disease. The pathophysiology of these disorders may be associated with glutamate dysregulation, marked by a high rate of glutamate release and elevated expression of glutamate receptors and glutamate transporters in the CNS. The ability of acupuncture stimulation to modulate glutamate receptor and EAAT expression suggests that the treatment effects of acupuncture are underpinned by its intervention in the dysregulated glutamate system. Further preclinical and clinical studies are needed to clarify the possible mechanisms of acupuncture in these neuropsychiatric disorders and to establish protocols for treatment guidelines.

A Animal Study published in 2019 in the journal Frontiers in Neuroscience found that Gan Mai Da Zao decoction has shown comparable anxiolytic effects to Diazepam and Buspirone in mice, possibly regulated by serotonin and gamma-aminobutyric acid receptors. The mice were given the Gan-Mai-Da-Zao (GMDZ) decoction orally at different concentrations for a week, with Diazepam and Buspirone serving as positive controls. Anxiety-level testing was conducted using a combination of the elevated plus-maze, light/dark box, marble burying, open field, and rota-rod tests, providing a comprehensive assessment of the decoction's effects on mice. Furthermore, the anxiolytic effects that GMDZ induced in the mice were challenged by the application of Flumazenil, a gamma-aminobutyric acid-A receptor antagonist, and WAY-100635, a serotonin-1A receptor antagonist. They found that the effects were successfully inhibited, indicating that the mechanism of action of GMDZ could be linked to both the serotonin and gamma-aminobutyric acid receptors in the nervous system, thereby reducing anxiety-like behavior in mice.

A Randomised Controlled Trial published in 2019 in the journal Acta Obstetricia et Gynecologica Scandinavica found that Acupuncture during IVF treatment can possibly lower anxiety at the time of embryo transfer but seems to have no long-term impact on women's quality of life. A multicenter randomised controlled trial was conducted recruiting women between 18 to 42 years, who were already undergoing a fresh IVF cycle and not using acupuncture. The experiment ran between June 2011 and October 2015 in Australia and New Zealand. Random assignments placed participants in either the acupuncture group or a control group which received sham acupuncture. Three treatments were administered in total - the first between the 6th and 8th day of ovarian stimulation, and the other two on the day of the embryo transfer. The results of the study highlighted that participants who received acupuncture reported experiencing significantly less anxiety following the embryo transfer. However, no discernible difference was found between the groups in terms of quality of life following the embryo transfer. The apparent benefit of acupuncture on the general health of participants was not sustained 14 weeks after the trial, which indicates that acupuncture might not have a long-term impact on a woman's emotional well-being following an IVF cycle.

A Systematic Review published in 2018 in the journal Current Opinion in Clinical Nutrition and Metabolic Care found that Most bioactive walnut micronutrients synergize to affect multiple metabolic pathways leading to protection from chronic noncommunicable diseases. Nuts in general and walnuts in particular are in the limelight for the association of their consumption with improved health outcomes. Walnuts have an optimal composition in bioactive nutrients and recent clinical and experimental studies have uncovered a number of beneficial effects of walnut micronutrients, working in isolation or in concert, on metabolic pathways and clinical outcomes that make this review timely and relevant. Alpha-linolenic acid, a critical walnut component, is metabolized into bioactive oxylipins, has been shown to protect microglial cells from inflammation, and is associated with lower fatal myocardial infarction rates through a putative antiarrhythmic effect. Phytosterols relate to the cholesterol-lowering effect of nut consumption. Nonsodium minerals are associated with better cardiometabolic health. Walnut phytomelatonin has anticancer effects that are shared by the main walnut polyphenols and their metabolites, ellagitannins and urolithins, respectively. This review highlights new evidence on the health-promoting properties of walnuts and their main micronutrient components. The conclusion is that walnuts are optimal healthful foods.

A Randomised Controlled Trial published in 2018 in the journal American Journal of Therapeutics found that Cherry juice increases sleep time and efficiency in older adults with insomnia, potentially due to its inhibition of a process that degrades tryptophan and stimulates inflammation. The study followed a placebo-controlled balanced crossover design, with subjects older than 50 years old with insomnia being randomized to either placebo or cherry juice consumption twice daily for two weeks, with a two-week washout period in between. Sleep was evaluated using polysomnography and five validated questionnaires, while serum measurements were conducted for several bio-indicators. In vitro studies were also performed to determine the ability of cherry juice components to inhibit a specific physiological process. The study found that sleep time increased by 84 minutes per polysomnography evaluations and sleep efficiency increased per the Pittsburgh Sleep Quality Index. Serum measurements revealed decreased levels of certain bio-indicators suggesting reduced inflammation. In vitro studies also found that components present in cherry juice inhibited a specific process that degrades the amino acid tryptophan, potentially leading to these improved sleep outcomes. Other questionnaires, however, showed no significant differences in results.

A Systematic Review published in 2018 in the journal Medicine found that Acupuncture might have effect in decreasing the number of micturition episodes, incontinence episodes, and nocturia episodes. Overactive bladder is stated as the occurrence of urinary urgency which will cause negative impacts and decrease patients’ health-related quality of life. The aim of this systematic review is to assess the efficiency and safety of acupuncture for adults with overactive bladder (OAB) comparing with sham-acupuncture, drugs, and acupuncture plus drugs. Acupuncture might have effect in decreasing the number of micturition episodes, incontinence episodes, and nocturia episodes. However, the evidence is insufficient to show the effect using acupuncture alone or the additional effect to drugs in treating OAB.

A Animal Study published in 2018 in the journal Journal of Traditional and Complementary Medicine found that Gan Mai Da Zao Tang, a traditional herbal formula, produced substantial antidepressant-like effects in rats by regulating monoamine neurotransmitters. The researchers studied the antidepressant effects of Gan-Mai-Da-Zao-Tang and its constituent ingredients in rats subjected to the forced swim test. 72 male Nerl: Wistar rats aged 8 weeks were divided into groups receiving either a control solution, licorice, wheat, jujube, Gan-Mai-Da-Zao-Tang in a specific ratio, or Prozac. These substances were administered orally for 21 days. On the final day, the forced swimming test was performed which initially involved a pretest lasting 15 minutes followed by a 5 minute real test. Following this, the rats were euthanized and their brain tissues were collected for analysis of monoamine concentrations. Discussion on the results revealed that the Gan-Mai-Da-Zao-Tang group exhibited significantly reduced immobility time and certain monoamine turnover rates, and showed an increase in concentration of some neurotransmitters in the brain tissues compared to the control group. This indicates a potent antidepressant-like effect by modulating these monoamines concentrations. In contrast, the licorice, wheat, and jujube groups didn't display significant differences when compared with the control group. Prozac, the positive control, resulted in significant reductions in body weight and appetite.

A Review Article published in 2018 in the journal Journal of Pharmacy And Bioallied Sciences found that Saffron possesses major bioactive compounds such as safranal, crocin, and picrocrocin that are hypothesized to be integral to its antidepressant effects. In this research, a chemical analysis was undertaken on the saffron plant, a perennial herb native to various mountainous regions, ranging from Asia Minor to India. During this in-depth analysis, the researchers identified and elucidated almost 150 volatile and nonvolatile compounds from the plant. A key focus of the analysis was the three major bioactive compounds - safranal, crocin, and picrocrocin, believed to be the primary factors behind saffron's aroma and bitter taste. On the subject of the findings, it was concluded that these major bioactive compounds are likely playing a pivotal role in the medicinal potential of the saffron plant. Specifically, the plant's well-documented antidepressant properties could largely be attributed to these compounds. The study also focused on the pharmacokinetic and pharmacodynamic properties of the plant, indicating that saffron could have efficacious and safe potential for use. It was inferred that this potential mainly pertains to its antidepressant effects, spurring increased interest in further exploration of its assorted bioactive compounds.

A Systematic Review published in 2017 in the journal Phytomedicine found that Green tea consumption was shown to reduce psychopathological symptoms like anxiety and was also shown to effect cognition, with noted benefits for memory and attention. Green tea was also linked with the activation of working memory as seen in functional MRI. The effects of green tea cannot be attributed to a single constituent of the beverage. This is exemplified in the finding that beneficial green tea effects on cognition are observed under the combined influence of both caffeine and l-theanine, whereas separate administration of either substance was found to have a lesser impact.

A Practice Guideline published in 2017 in the journal Maturitas found that Long-chain omega-3 polyunsaturated fatty acids have various health benefits for postmenopausal women including reducing triglycerides and improving depression and psychotic symptoms. A panel of experienced experts from the Spanish Menopause Society embarked to establish a comprehensive set of recommendations for the intake of long-chain omega-3 polyunsaturated fatty acids by postmenopausal women. This was steered based on the best available evidence and research. It was especially noted that the consumption of these fatty acids, at doses higher than 3 grams per day, proved to significantly decrease the levels of triglycerides in the body. The results obtained from this study are promising and underline the potential health benefits of long-chain omega-3 polyunsaturated fatty acids for postmenopausal women. Alongside reducing triglyceride levels, they also contribute to antiarrhythmic effects, reduction in blood pressure, and improvements in depressive and psychotic symptoms. Furthermore, it was noted that their consumption does not increase the risk of cancer in these women. The potential of these fatty acids in providing relief from menopause symptoms and osteoporosis was also explored, yielding positive indications.

A Randomised Controlled Trial published in 2017 in the journal Journal of Physics Conference Series found that Acupuncture treatment effectively improved the quality of sleep and the quality of life for chronic hemodialysis patients. Twenty-eight hemodialysis patients suffering from insomnia were divided randomly into two groups, an acupuncture group (n = 15) who received acupuncture treatment at the points HT7 Shenmen, PC6 Neiguan, GV20 Baihui, and EX-HN1 Sishenchong, anda control group (n = 13) who underwent a sham procedure in which a needle was inserted into an elastic bandage at the same points. The acupuncture treatment was done during hemodialysis twice a week for five weeks. PSQI scores and the WHOQOL-BREF were assessed before treatment, after the fifth treatment, and at the end of the treatment. Significant differences were found in the PSQI score and in the WHOQOL-BREF between the acupuncture group and the control group by the end of the period of treatment. Acupuncture treatment effectively improved the quality of sleep and the quality of life for these chronic hemodialysis patients.

A Clinical Study published in 2017 in the journal Mindfulness found that iRest Yoga Nidra combined with acupuncture significantly improves psychological health in veterans compared to using acupuncture alone. The study employed iRest Yoga Nidra, a mindfulness approach that promotes relaxation and focused attention, along with acupuncture. Initially developed for military use, iRest was combined with acupuncture in this exploratory study to determine its effectiveness. Specifically, this was tested on veterans with a view to improving their psychological health. Throughout the study, the participants were exposed to principles such as non-judgment and observation of opposing feelings and emotions, along with the inclusion of these principles into their everyday life. The analysis of results showed that the combined therapy using iRest and acupuncture had a marked effect on psychological health. There were significant improvements in areas such as depression, psychological symptom severity, depression or tension as a result of pain, and the emotional interference with activities of daily life. Conversely, the group that had only undergone acupuncture treatment showed no significant benefits in these areas. Also significant was that the comfort shown by the treatment group was a moderate to high degree in contrast to the low comfort experienced by the group receiving only acupuncture. The overall treatment condition demonstrated considerable changes, with veterans reporting substantive decreases in the levels of mild, moderate, and severe depression. Additionally, it was indicated that the benefits of the combined treatment did not differ across factors such as age, gender, or race.

A Experimental Study published in 2017 in the journal Mental Health Clinician found that Lavender essential oil, particularly its primary constituents linalool and linalyl acetate, may offer a beneficial anxiolytic effect through its interaction with certain neurological mechanisms. The methodology used in this research involved studying lavender essential oil as an option in aromatherapy for anxiety disorders. This focused on the variability in the constituents, specifically the two primary terpenoid components, linalool and linalyl acetate. In order to comprehend the anxiolytic effect of these constituents, their interaction with neurological mechanisms such as voltage-gated calcium channels, reduction of 5HT1 receptor activity and the parasympathetic tone were studied. The obtained results revealed that lavender essential oil has notable potential in treating anxiety disorders due to its interaction with certain neurological mechanisms. This potential anxiolytic effect stems primarily from its two key components, linalool and linalyl acetate. The level of efficacy currently recommended is not yet approved by the Food and Drug Administration, but promises a possible future pathway for a novel treatment, given the limitations of existing pharmacotherapy for anxiety disorders. The current safety profile of lavender oil presented within this study supports these findings.

A Review Article published in 2017 in the journal Evidence-Based Complementary and Alternative Medicine found that Jujube possesses neuroprotective activities, including protecting neuronal cells against neurotoxin stress, stimulating neuronal differentiation, increasing expression of neurotrophic factors, and promoting memory and learning. Jujube possesses neuroprotective activities, including protecting neuronal cells against neurotoxin stress, stimulating neuronal differentiation, increasing expression of neurotrophic factors, and promoting memory and learning. Flavonoid, cAMP, and jujuboside could be the potential bioactive ingredients to account for the aforesaid biological activities. These findings imply that jujube is a potential candidate for development of health supplements for prevention and/or treatment of neurological diseases.

A Systematic Review published in 2017 in the journal Sleep Medicine Reviews found that The severity of primary restless legs syndrome symptoms can be significantly ameliorated by acupuncture. Complementary and alternative therapies have been found to be effective in both primary and secondary restless legs syndrome (RLS). The severity of primary RLS symptoms can be significantly ameliorated by exercise training, transcutaneous spinal direct current stimulation, pneumatic compression devices, light therapy, repetitive transcranial magnetic stimulation, and acupuncture. Pneumatic compression devices and yoga also improve RLS-related disorders. Exercise training is highly efficacious in the reduction of symptom severity in uremic RLS and related effects such as poor quality of life. Endovenous laser ablation may be a good choice for patients with concurrent RLS and superficial venous insufficiency.

A Animal Study published in 2017 in the journal Holistic Nursing Practice found that Curcumin's potential anxiolytic and antidepressant impacts do not significantly alter behavior or interact with the benzodiazepine site of the gamma-aminobutyric acid receptor A. In this study, a prospective, between-subjects group design was employed. The subjects were 55 male Sprague-Dawley rats randomly split into five groups, each given different intraperitoneal injections: a control group, curcumin, curcumin with flumazenil, midazolam alone, and midazolam with curcumin. Behavioral observations were conducted with the aid of the elevated plus maze, open field test, and forced swim tests. A two-tail multivariate analysis of variance was deployed for data analysis. The results showed that, according to the behavioral tests, curcumin did not generate any notable signs of anxiety-relieving or mood-lifting effects. It was also noticed that curcumin didn't show any interactive tendencies with the GABAA receptor's benzodiazepine site. The team therefore concluded that curcumin didn't produce any significant outcomes on these aspects of mental health modulation as was purposed in the initial hypothesis.

A Randomised Controlled Trial published in 2017 in the journal Sleep and Biological Rhythms found that Kiwifruit consumption before bedtime significantly improves sleep quality and daytime function in individuals with chronic insomnia in comparison to pear consumption. In the methodology of this study, participants with chronic insomnia symptoms were randomly assigned to consume either 130g of kiwi or pear an hour prior to bedtime daily for a period of 4 weeks. This followed a baseline assessment period of one week. Various outcome measures such as sleep diaries, actigraphy, and several questionnaires were used to evaluate the effects of this dietary change. The results showed a distinct improvement in sleep quality and daytime functionality in participants who consumed kiwi, as reported in the sleep diaries. However, the objective measures such as actigraphy and certain questionnaires did not show any significant changes. Hence, the research indicates that kiwi might have properties that enhance sleep, especially in people dealing with chronic insomnia.

A Clinical Study published in 2016 in the journal Neuropediatrics found that Saffron has shown potential as an effective and tolerable treatment for major depressive disorder with anxious distress. In the study, 66 patients suffering from major depressive disorder with anxious distress were randomly chosen to be treated either with 30 mg of saffron per day or 40 mg of citalopram per day for a duration of 6 weeks. Their progress was monitored using the Hamilton Rating Scale for Depression and the Hamilton Rating Scale for Anxiety, which aided in evaluating the effects of the treatment throughout the trial. In the results observed, it was found that patients from both groups, those treated with saffron and those administered with citalopram, demonstrated significant improvement in their depression and anxiety scales. The change in the scores between the two groups was examined and it was found that there was no profound difference. Interestingly, the frequency of side effects appearing was also not significantly varied between the two groups. This study hence showcases saffron as a potential reliable and well-tolerated treatment for major depressive disorder accompanied with anxious distress.

A Systematic Review published in 2016 in the journal Cochrane Database of Systematic Reviews found that Acupuncture may have beneficial effects on improving dependency, global neurological deficiency, and some specific neurological impairments for people with stroke in the convalescent stage, with no obvious serious adverse events. Although acupuncture may have positive effects in stroke rehabilitation and there were no reported serious adverse events, the small number of low quality studies and the probability of publication bias means that there was insufficient evidence to support the routine use of acupuncture for people with subacute or chronic stroke.

A Systematic Review published in 2016 in the journal BMC Complementary Medicine and Therapies found that Our results suggest that acupuncture could be effective for treating insomnia after stroke. A total of 165 studies were identified; 13 RCTs met our inclusion criteria. Meta-analysis showed that acupuncture appeared to be more effective than drugs for treatment of insomnia after stroke, as assessed by the PSQI and by the efficacy standards of Chinese medicine. Intradermal acupuncture had significant effects compared with sham acupuncture, as assessed by the ISI and the AIS.

A Systematic Review published in 2015 in the journal Sleep Medicine found that Chinese herbal medicine was superior to placebo and benzodiazepine drugs and was superior to benzodiazepines and psychotherapy alone as an adjunct therapy in terms of subjective sleep quality and quantity and safety. In this study, we systematically reviewed 79 RCTs investigating a variety of Chinese herbal medicine (CHM) treatments for participants with insomnia. We also performed meta-analyses to estimate the efficacy of CHM on subjective sleep quality assessed by validated instruments, patient-rated sleep parameters, clinician-reported severity, and PSG results, as well as to determine the safety of CHM. Overall, this systematic review and meta-analysis showed that CHM was superior to placebo and benzodiazepine drugs (BZDs) when used as a monotherapy and was superior to BZDs and psychotherapy alone as an adjunct therapy in terms of subjective sleep quality and quantity and safety. CHM was not associated with more benefit than non-BZDs, although the risks were less. These results suggest that CHM could be a promising alternative therapy with a good benefit–risk ratio.

A Systematic Review published in 2015 in the journal Explore: The Journal of Science & Healing found that Acupuncture seems to be an effective add-on treatment in patients with depression and, to a lesser degree, in patients with schizophrenia. The overall clinical results on using acupuncture to treat depression are promising, but only limited evidence for its effectiveness in treating schizophrenia was found. Acupuncture improves the quality of life, particularly that of sleep, in psychiatric patients. Brain research has revealed that acupuncture has a modulating and normalizing effect on the limbic–paralimbic–neocortical network (LPNN), including the default mode network. Because the LPNN is related to sleep and emotions, this might explain the improved qualities of life and sleep after acupuncture.

A Review Article published in 2015 in the journal The FASEB Journal found that Serotonin function, influenced by vitamin D and omega-3 fatty acids, plays a critical role in neuropsychiatric disorders and certain behavioral functions. The paper synthesizes prior research into serotonin's role in managing various brain functions and behaviours, and how its dysfunction is commonly seen in conditions like attention deficit hyperactivity disorder, bipolar disorder, schizophrenia, and impulsive behavior. The researchers then put forward potential mechanisms showing the influence of vitamin D and the marine omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid, on serotonin synthesis, release, and function in the brain. Serotonin in the brain is synthesized from tryptophan by tryptophan hydroxylase 2, a process that is activated by a vitamin D hormone. Possible mechanisms proposed include eicosapentaenoic acid increasing serotonin release from presynaptic neurons by lowering E2 series prostaglandins, and docosahexaenoic acid affecting serotonin receptor action by increasing cell membrane fluidity in postsynaptic neurons. The study posits that suboptimal levels of vitamin D and omega-3 fatty acids, in combination with genetic factors at key developmental stages, could lead to dysfunctional serotonin activation and function – a possible underlying mechanism behind neuropsychiatric disorders and depression. The paper suggests that optimizing vitamin D and marine omega-3 fatty acid intake could potentially curtail and modulate the severity of brain dysfunction.

A Systematic Review published in 2015 in the journal Evidence-Based Complementary and Alternative Medicine found that TCM pattern-based treatments for depression frequently use Xiao Yao and Chai Hu Shu Gan decoctions, with Bai Shao and Chai Hu herbs common across different TCM patterns. The methodology incorporated a systematic review of randomized controlled trials from both Chinese and English literatures regarding traditional Chinese medicine (TCM) pattern-based treatments for depression. This encompassed a total of 61 studies and 2504 subjects across 27 TCM patterns. Due to varied TCM patterns among participants, the analysis focused on the four most prevalent ones: liver qi depression, liver depression and spleen deficiency, dual deficiency of the heart and spleen as well as liver depression and qi stagnation. In the discussion of results, it was found that Xiaoyao decoction was most frequently used for the treatment of liver qi depression and liver depression with spleen deficiency, whereas Chaihu Shugan decoction was typically used for liver depression and qi stagnation. Commonly used herbs regardless of the prescribed Chinese herbal formulas included Bai Shao and Chai Hu. Typically, the individual studies did not provide an underlying rationale for herb selection, limiting the conclusions one could draw regarding the efficacy of certain herbal formulas and the response of specific TCM patterns to these treatments.

A Systematic Review published in 2014 in the journal Human Psychopharmacology: Clinical and Experimental found that Saffron, derived from Crocus sativus flower, shows similar efficacy to antidepressant medications in treating major depression, potentially due to its variety of biochemical effects. In the methodical study, electronic databases were consulted to find high-quality, randomized, double-blind studies that had either placebo or antidepressant controls. Six distinct studies were found through this process. In vivo and in vitro studies were reviewed to better comprehend the potential antidepressant mechanisms of action saffron brings forth. The results showed that in the studies compared with a placebo, saffron had large beneficial effects. When compared with regular antidepressant medication, saffron demonstrated similar levels of efficacy. The potential mechanisms behind saffron's antidepressant qualities seemingly lay in its serotonergic, antioxidant, anti-inflammatory, neuro-endocrine, and neuroprotective effects.

A Experimental Study published in 2014 in the journal Evidence-Based Complementary and Alternative Medicine found that Honey, specifically its polyphenols, show promising signs of enhancing memory and counteracting neurodegenerative diseases by reducing oxidative stress and neuroinflammation. The research focuses on the analysis of the nootropic and neuropharmacological benefits of honey, with particular emphasis on its polyphenol constituents. Essentially, honey's nutritional and physiological effects on memory enhancement and various neurological activities have been examined. This study delves into the mechanistic approach in which honey, as a natural compound, can mitigate oxidative stress while enhancing the cellular antioxidant defense system - a cue to its potential role in neutralizing reactive oxygen species that have harmful effects on neurological health. The findings from the research suggest that honey and its polyphenols play a noteworthy role in neuronal health. They display a potential ability to improve memory deficits and other neurodegenerative diseases. In particular, honey polyphenols have been associated with apoptosis activities and the reduction of microglia-induced neuroinflammation. Furthermore, the direct involvement of these polyphenols in synaptic plasticity was found, which could have a substantial effect on the behavior-modulating neural circuitry. Overall, these findings indicate the possible therapeutic value of honey and its polyphenols on the health of the neurological system.

A Systematic Review published in 2013 in the journal Evidence-Based Complementary and Alternative Medicine found that Evidence of effectiveness of acupuncture for PTSD is encouraging but not cogent. Acupuncture may be a relatively safe alternative for PTSD in contrast to SSRI, if long-term therapy is needed for treatment. This is the first systematic review and meta-analysis of prospective clinical trials on the effectiveness of acupuncture for treatment of PTSD. Only 4 RCTs and 2 UCTs met the inclusion criteria for this review. Our main finding of this review is that acupuncture is effective for PTSD based on one high-quality RCT and a meta-analysis. Acupuncture has positive effects in PTSD patients, although the evidence is still lacking as to its true efficacy for this condition.

A Systematic Review published in 2013 in the journal International Review of Neurobiology found that The clinical efficacy of acupuncture appeared to be supported by evidence obtained from basic neuroendocrinological studies. A number of studies have demonstrated that acupuncture may modulate a wide range of neuroendocrinological factors following stimulation of acupoints. Evidence has suggested that the clinical efficacy of acupuncture in treatment of insomnia is potentially mediated by a variety of neurotransmitters including norepinephrine, melatonin, gamma-aminobutyric acid, and β-endorphin. However, due to the complexity, these findings are far from conclusive. More research is necessary. More rigors methodology and integrated approach to evaluate both clinical and basic research evidence are required for future studies.

A Experimental Study published in 2013 in the journal Evidence-Based Complementary and Alternative Medicine found that Pomegranate juice can enhance memory function and brain activity in tasks related to verbal and visual memory in older adults experiencing memory problems. The study was a preliminary, placebo-controlled, randomized trial involving 32 older participants with memory complaints. They were randomly tasked to consume 8 ounces of either pomegranate juice or a placebo drink that had a similar flavor daily for a duration of 4 weeks. Before and after the study duration, the subjects underwent memory tests and functional MRI scans while involved in cognitive tasks. Additionally, blood samples were extracted to ascertain peripheral biomarkers. The test subjects and investigators were oblivious to the groupings to ensure objectivity. The results from the study pointed out that the group that had pomegranate juice had notable improvements in their verbal memory as determined by the Buschke selective reminding test and also a rise in their antioxidant capacity. This group also recorded increased fMRI activity during tasks related to verbal and visual memory in comparison to the placebo group. This may suggest that consumption of pomegranate juice may boost memory function by elevating functional brain activity during tasks.

A Clinical Study published in 2013 in the journal Journal of Nutritional Science found that Consuming two kiwifruits daily can improve overall mood, particularly for individuals starting with moderate mood disturbance. The research study investigated the potential mood-enhancing effects of kiwifruit, involving a sample group of 35 young adult males who were supplemented with either half or two kiwifruits a day for 6 weeks. Through this observational period, their moods were evaluated with the use of Profile of Mood States questionnaires that were administered at the start and end of the intervention. In the results discussion, it was noted that there was no observable effect on overall mood for the group that consumed half a kiwifruit daily. However, interestingly, for those who consumed two kiwifruits daily, there was a trend towards a decrease in total mood disturbance as well as depression. This was especially significant among participants with higher initial mood disturbance, showing decrease in mood disturbance and fatigue, and increase in vigour. This research also observed a significant increase in dietary vitamin C intake and corresponding plasma levels among the participants. There was no apparent effect of consuming two kiwifruits daily on the mood scores of participants with low initial mood disturbance.

A Systematic Review published in 2011 in the journal Cochrane Database of Systematic Reviews found that Acupuncture might result in improvement in some outcomes in children with autism spectrum disorders. When needle acupuncture plus conventional treatment was compared to sham acupuncture plus conventional treatment, the intervention seemed to result in better language comprehension, cognition, self‐care, social function and a higher likelihood of greater than or equal to 25% improvement in global function. Compared to conventional treatment alone, needle acupuncture plus conventional treatment might result in an overall improvement in autistic features, speech, cognition, global functioning, self‐care, sensory functioning, imitation, repetitive behaviour, and physical health. Compared to conventional treatment alone, acupressure plus conventional treatment might result in improvement in overall global functioning, communication attitude, non‐verbal communication and matching, and language and social interaction.

A Randomised Controlled Trial published in 2010 in the journal Journal of Medicinal Food found that Tart cherry juice blend yielded modest improvements in sleep for older adults with insomnia, exhibiting effects similar to or better than natural products like valerian and melatonin. In the pilot study, 15 older adults who were suffering from chronic insomnia but were otherwise healthy participated in a randomized, double-blind, crossover design. The study lasted for 6 weeks, with each participant receiving both the proprietary tart cherry juice blend and a placebo for 2 weeks with a 2-week washout period between the two treatments. Sleep continuity and insomnia severity were evaluated by analyzing 2-week mean values derived from daily sleep diaries and the Insomnia Severity Index respectively. The tart cherry juice blend was found to bring significant improvements in all assessed sleep variables before and after treatment. These improvements were particularly noticed in reducing insomnia severity, specifically the minutes awake after sleep onset, compared to placebo. Sleep latency, total sleep time, or sleep efficiency didn't show any notable improvements compared to placebo. The benefits of the tart cherry juice on sleep for older adults with insomnia were in the range of effect sizes seen in studies using valerian or melatonin, which are the most commonly studied natural products for insomnia. But these effects were considerably less than evidence-based insomnia treatments such as hypnotic agents and cognitive-behavioral therapies.

A Systematic Review published in 2009 in the journal The Journal of Alternative and Complementary Medicine found that Clinical studies have shown that acupuncture may have a beneficial effect on insomnia compared with Western medication. Forty-six (46) randomized trials involving 3811 patients were included, and the methodological quality of trials was generally fair in terms of randomization, blinding, and intention-to-treat analysis. Meta-analyses showed a beneficial effect of acupuncture compared with no treatment and real acupressure compared with sham acupressure on total scores of Pittsburgh Sleep Quality Index. Acupuncture was superior to medications regarding the number of patients with total sleep duration increased for >3 hours. However, there was no difference between acupuncture and medications in average sleep duration. Acupuncture plus medications showed better effect than medications alone on total sleep duration. Similarly, acupuncture plus herbs was significantly better than herbs alone on increase of sleep rates. There were no serious adverse effects with related to acupuncture treatment in the included trials.

Moderation Tools

---

Topic